CIK 0001544227 · Non-accelerated filer<br>Smaller reporting company
Tempest Therapeutics, Inc.
Sign in to watch- Ticker
- TPST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451472564
- Phone
- 415-798-8589
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
- Former names
- Millendo Therapeutics, Inc., OvaScience, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Whiting Samuel Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +69,700 | 69,700 | ||
| 2023-01-03 | Dubensky Thomas W. President | Grant or award · Employee Stock Option (right to buy) | +102,700 | 102,700 | ||
| 2023-01-03 | Brady Stephen R Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +177,300 | 177,300 | ||
| 2023-01-03 | Maestas Nicholas VP of Strategy and Finance | Grant or award · Employee Stock Option (right to buy) | +38,425 | 38,425 | ||
| 2023-01-03 | Trojanowski Justin Corporate Controller | Grant or award · Employee Stock Option (right to buy) | +20,300 | 20,300 | ||
| 2022-10-03 | Trojanowski Justin Corporate Controller | Grant or award · Employee Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-06-21 | Lorenzo Pierre Corporate Controller | Grant or award · Stock Option (Right to Buy) | +8,477 | 8,477 | ||
| 2022-06-21 | Maestas Nicholas VP of Strategy and Finance | Grant or award · Stock Option (Right to Buy) | +51,270 | 51,270 | ||
| 2022-06-21 | Whiting Samuel Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,680 | 55,680 | ||
| 2022-06-21 | Dubensky Thomas W. President | Grant or award · Stock Option (Right to Buy) | +87,801 | 87,801 | ||
| 2022-06-21 | Brady Stephen R Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +173,533 | 173,533 | ||
| 2022-06-17 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2022-06-17 | NICHOL GEOFFREY Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2022-06-17 | Woiwode Thomas Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2022-06-17 | Simantov Ronit Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2022-06-17 | RAAB MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2022-04-29 | Woiwode Thomas Director | Purchase | +2,118,644 | $2.36 | $5.0M | 2,118,644 |
| 2022-01-07 | Dubensky Thomas W. President | Purchase | +2,000 | $4.78 | $10K | 113,343 |
| 2022-01-06 | Whiting Samuel Chief Medical Officer | Purchase | +1,700 | $4.80 | $8K | 1,901 |
| 2022-01-04 | Lorenzo Pierre Corporate Controller | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 |
Page 3 of 6 · 119 trades